The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Lack of association between COMT gene and deficit/nondeficit schizophrenia.
Ikwunga Wonodi; Braxton D Mitchell; O Colin Stine; L Elliot Hong; Amie Elliott; Brian Kirkpatrick; William T Carpenter; Gunvant K Thaker; Robert W Buchanan (Profiled Author: O'Colin Stine)
Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, PO Box 21247, Baltimore, Maryland 21228, USA. firstname.lastname@example.org
Behavioral and brain functions : BBF 2006;2():42.
BACKGROUND: The dopamine dysregulation hypothesis of schizophrenia posits that positive, negative and cognitive symptoms correlate with cortical/subcortical imbalances in dopaminergic transmission. A functional polymorphism (Val158Met) in the catechol-O-methyltransferase (COMT) gene is implicated in the pathophysiology of schizophrenia by its effect on prefrontal dopamine transmission, and its unique impact on prefrontal cognitive and behavioral phenotypes. Cognitive impairments and negative symptoms in schizophrenia have been hypothesized to be associated with hypodopaminergic states. Schizophrenia patients with the deficit syndrome are characterized by primary enduring negative symptoms, impairment on neurocognitive tasks sensitive to frontal and parietal cortical functioning, and poorer functional outcome compared to non-deficit patients. METHODS: Eighty-six schizophrenia cases that met DSM-IV criteria for schizophrenia were recruited. Additional categorization into deficit and nondeficit syndrome was performed using the Schedule for the Deficit Syndrome (SDS). A healthy comparison group (n = 50) matched to cases on age and ethnicity was recruited. Allele and genotype frequencies of the Val158Met polymorphism were compared among healthy controls, and schizophrenia cases with the deficit (n = 21), and nondeficit syndrome (n = 65). RESULTS: There was a significant difference in Val/Val genotype frequencies between schizophrenia cases (combined deficit/nondeficit) and healthy controls (p = 0.004). No significant differences in allele or genotype frequencies were observed between deficit and nondeficit cases. CONCLUSION: Results from this preliminary analysis failed to show an effect of COMT gene on deficit schizophrenia.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Joshua L Roffman; Randy L Gollub; Vince D Calhoun; Thomas H Wassink; Anthony P Weiss; Beng C Ho; Tonya White; Vincent P Clark; Jill Fries; Nancy C Andreasen; et al.Proceedings of the National Academy of Sciences of the United States of America 2008;105(45):17573-8.
Gunvant K Thaker; Ikwunga Wonodi; Matthew T Avila; L Elliot Hong; O Colin StineThe American journal of psychiatry 2004;161(12):2320-2.
I Kremer; M Pinto; I Murad; M Muhaheed; I Bannoura; D J Muller; T G Schulze; A Reshef; M Blanaru; S Gathas; et al.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2003;119B(1):35-9.
Jana Strohmaier; Josef Frank; Jens R Wendland; Johannes Schumacher; Rami Abou Jamra; Jens Treutlein; Vanessa Nieratschker; René Breuer; Manuel Mattheisen; Stefan Herms; et al.Schizophrenia research 2010;118(1-3):98-105.
Appears in this Publication
Author of this Publication